Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
27.64
USD
|
-0.11%
|
|
-10.11%
|
+186.13%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
203.4
|
93.74
|
25.16
|
179.8
|
79.46
|
76.05
|
Enterprise Value (EV)
1 |
1,195
|
1,258
|
917.1
|
784.7
|
733.6
|
701.4
|
P/E ratio
|
-3.78
x
|
-2.6
x
|
-0.09
x
|
0.75
x
|
-1.35
x
|
-2.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.45
x
|
0.21
x
|
0.07
x
|
0.93
x
|
0.38
x
|
0.32
x
|
EV / Revenue
|
2.61
x
|
2.84
x
|
2.56
x
|
4.05
x
|
3.48
x
|
2.99
x
|
EV / EBITDA
|
19.5
x
|
26.8
x
|
19.3
x
|
128
x
|
76.9
x
|
28.3
x
|
EV / FCF
|
34.1
x
|
143
x
|
31.6
x
|
-27.3
x
|
-35.3
x
|
243
x
|
FCF Yield
|
2.93%
|
0.7%
|
3.17%
|
-3.67%
|
-2.83%
|
0.41%
|
Price to Book
|
5.77
x
|
6.52
x
|
-0.09
x
|
-3.85
x
|
-0.78
x
|
-0.63
x
|
Nbr of stocks (in thousands)
|
1,994
|
2,022
|
2,039
|
6,310
|
6,356
|
7,873
|
Reference price
2 |
102.0
|
46.35
|
12.34
|
28.49
|
12.50
|
9.660
|
Announcement Date
|
3/1/19
|
3/31/20
|
3/31/21
|
4/15/22
|
3/30/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
457
|
443.3
|
358.9
|
193.8
|
211.1
|
234.2
|
EBITDA
1 |
61.23
|
47
|
47.56
|
6.119
|
9.541
|
24.8
|
EBIT
1 |
-1.597
|
-17.19
|
-12.75
|
-31.75
|
-28.91
|
-15.09
|
Operating Margin
|
-0.35%
|
-3.88%
|
-3.55%
|
-16.38%
|
-13.7%
|
-6.44%
|
Earnings before Tax (EBT)
1 |
-55.37
|
-35.58
|
-295
|
126.2
|
-54.32
|
-20.85
|
Net income
1 |
-53.6
|
-36.03
|
-295.4
|
125.6
|
-54.4
|
-21.11
|
Net margin
|
-11.73%
|
-8.13%
|
-82.29%
|
64.81%
|
-25.77%
|
-9.01%
|
EPS
2 |
-27.00
|
-17.86
|
-144.1
|
37.92
|
-9.273
|
-3.850
|
Free Cash Flow
1 |
35.03
|
8.765
|
29.05
|
-28.78
|
-20.8
|
2.888
|
FCF margin
|
7.66%
|
1.98%
|
8.09%
|
-14.85%
|
-9.85%
|
1.23%
|
FCF Conversion (EBITDA)
|
57.21%
|
18.65%
|
61.08%
|
-
|
-
|
11.65%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
3/31/20
|
3/31/21
|
4/15/22
|
3/30/23
|
3/27/24
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
1 |
-21.85
|
-2.810
|
-1.340
|
-2.340
|
-2.790
|
2.760
|
-2.110
|
-2.170
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/15/22
|
5/23/22
|
8/12/22
|
11/14/22
|
3/30/23
|
5/11/23
|
8/14/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
991
|
1,164
|
892
|
605
|
654
|
625
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
16.19
x
|
24.76
x
|
18.76
x
|
98.87
x
|
68.56
x
|
25.21
x
|
Free Cash Flow
1 |
35
|
8.76
|
29
|
-28.8
|
-20.8
|
2.89
|
ROE (net income / shareholders' equity)
|
-92.6%
|
-145%
|
223%
|
-88.2%
|
171%
|
33.8%
|
ROA (Net income/ Total Assets)
|
-0.09%
|
-0.89%
|
-0.81%
|
-2.77%
|
-2.6%
|
-1.47%
|
Assets
1 |
62,612
|
4,053
|
36,528
|
-4,530
|
2,093
|
1,436
|
Book Value Per Share
2 |
17.70
|
7.110
|
-136.0
|
-7.410
|
-16.00
|
-15.40
|
Cash Flow per Share
2 |
15.70
|
11.80
|
8.720
|
12.50
|
2.660
|
0.5500
|
Capex
1 |
22
|
20.3
|
15.6
|
10.4
|
24.6
|
17.9
|
Capex / Sales
|
4.81%
|
4.58%
|
4.36%
|
5.39%
|
11.64%
|
7.66%
|
Announcement Date
|
3/1/19
|
3/31/20
|
3/31/21
|
4/15/22
|
3/30/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| +186.13% | 363M | | -23.43% | 2.2B | | +14.42% | 1.62B | | -34.18% | 1.23B | | +24.98% | 765M | | -12.73% | 425M | | -8.94% | 327M | | +15.10% | 147M | | +20.06% | 78.93M |
Residential & Long-Term Care
|